Alexion Pharmaceuticals, Inc. · 3 weeks ago
Data Sciences and Quantitative Biology Intern, Master’s and PhD Students
Alexion Pharmaceuticals, Inc. is seeking Master’s and PhD level students for a 10-week internship role in Data Sciences and Quantitative Biology. The role involves data integration and curation, insights and predictive modeling, as well as visualization and reporting of findings.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Data integration and curation: Aggregate data, QC, and harmonize internal and external chemical proteomics datasets (e.g. covalent datasets, molecular glues, chemoproteomics hits, compound/warhead annotations) into the in-house database
Insights and predictive modeling: Perform analyses and prototype models to predict drug–target affinity and generate prioritization scores for nominated targets
Visualization and reporting: Create dashboards/figures to communicate findings and deliver concise summaries to stakeholders
Qualification
Required
Master's and PhD level students majoring in Computational Biology, Bioinformatics, Computer Science, Machine Learning/Deep Learning or a related discipline. Candidates must have an expected graduation date after August 2026
Proficiency in programming in R and/or Python for data analysis, with familiarity in machine learning and deep learning methods and framework
Comfortability working with SQL relational databases (for example, PostgreSQL, MySQL, or SQLite) to query and integrate data is required
Ability to report onsite to Waltham, MA (preferred) OR Gaithersburg, MD 3-5 days per week. This role will not provide relocation assistance
US Work Authorization is required at time of application
This role will not be providing OPT support
Preferred
A basic understanding of molecular biology concepts relevant to chemical biology
Familiarity with mass spectrometry–based proteomics and drug-discovery
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Recent News
bloomberglaw.com
2025-12-20
Company data provided by crunchbase